{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:38:43Z","timestamp":1761831523988,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jacl.2014.07.009","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T17:31:54Z","timestamp":1405445514000},"page":"640-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Marked hypertriglyceridemia in a woman receiving metoprolol succinate"],"prefix":"10.1016","volume":"8","author":[{"given":"Yeunjung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2014.07.009_bib1","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2014.07.009_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1742-1241.1989.tb08673.x","article-title":"Acute pancreatitis due to nadolol-induced hypertriglyceridaemia","volume":"43","author":"O'Donoghue","year":"1989","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.jacl.2014.07.009_bib3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0002-9343(88)80111-6","article-title":"Massive hypertriglyceridemia associated with atenolol","volume":"85","author":"Haitas","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2014.07.009_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/080370599439463","article-title":"Beta-blocking agents in patients with insulin resistance: effects of vasodilating beta-blockers","volume":"8","author":"Jacob","year":"1999","journal-title":"Blood Press"},{"key":"10.1016\/j.jacl.2014.07.009_bib5","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2014.07.009_bib6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.clinbiochem.2009.05.018","article-title":"Hepatic insulin resistance, metabolic syndrome and cardiovascular disease","volume":"42","author":"Meshkani","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacl.2014.07.009_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0021-9150(97)00278-5","article-title":"Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk","volume":"137","author":"Boquist","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2014.07.009_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00041433-200210000-00002","article-title":"Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism","volume":"13","author":"Preiss-Landl","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2014.07.009_bib9","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1194\/jlr.R200015-JLR200","article-title":"Lipoprotein lipase: genetics, lipid uptake, and regulation","volume":"43","author":"Merkel","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2014.07.009_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00109-002-0351-5","article-title":"Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in\u00a0vivo","volume":"80","author":"Heeren","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/j.jacl.2014.07.009_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/erc.12.21","article-title":"Diagnosis and treatment of severe hypertriglyceridemia","volume":"10","author":"Viljoen","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacl.2014.07.009_bib12","first-page":"2347","article-title":"FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice","volume":"118","author":"Kamagate","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2014.07.009_bib13","doi-asserted-by":"crossref","first-page":"33997","DOI":"10.1074\/jbc.M113.495366","article-title":"Apolipoprotein C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets","volume":"288","author":"Larsson","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2014.07.009_bib14","first-page":"249","article-title":"Chylomicronemia syndrome","volume":"37","author":"Chait","year":"1992","journal-title":"Adv Intern Med"},{"key":"10.1016\/j.jacl.2014.07.009_bib15","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia","volume":"39","author":"Peterfy","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2014.07.009_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ncpcardio1326","article-title":"APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia","volume":"5","author":"Wang","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jacl.2014.07.009_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(96)00005-8","article-title":"Molecular pathobiology of the human lipoprotein lipase gene","volume":"70","author":"Murthy","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacl.2014.07.009_bib18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ajh.2012.54","article-title":"beta-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol","volume":"25","author":"Vardeny","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacl.2014.07.009_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.tpj.6500324","article-title":"beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene","volume":"5","author":"Iaccarino","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jacl.2014.07.009_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2796.2000.00669.x","article-title":"The Q\/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins","volume":"247","author":"Ehrenborg","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2014.07.009_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s001250051588","article-title":"Genetic and environmental nature of the insulin resistance syndrome in Indo-Mauritian subjects with premature coronary heart disease: contribution of beta3-adrenoreceptor gene polymorphism and beta blockers on triglyceride and HDL concentrations","volume":"44","author":"Manraj","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2014.07.009_bib22","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2014.07.009_bib23","doi-asserted-by":"crossref","first-page":"49B","DOI":"10.1016\/j.amjcard.2004.01.026","article-title":"Advantages of a third-generation beta-blocker in patients with diabetes mellitus","volume":"93","author":"Bell","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2014.07.009_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1463-1326.2008.00927.x","article-title":"Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients","volume":"11","author":"Bell","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacl.2014.07.009_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/hrt.2006.092379","article-title":"Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)","volume":"93","author":"Torp-Pedersen","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jacl.2014.07.009_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jash.2009.01.004","article-title":"Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial","volume":"3","author":"Fonarow","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacl.2014.07.009_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003495-198632040-00003","article-title":"The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs","volume":"32","author":"Ames","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.jacl.2014.07.009_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-126-12-199706150-00004","article-title":"Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial","volume":"126","author":"Giugliano","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2014.07.009_bib29","first-page":"123","article-title":"Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial","volume":"9","author":"Johnston","year":"1995","journal-title":"J Hum Hypertens"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287414002761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287414002761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:34:14Z","timestamp":1761831254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287414002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1933287414002761"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2014.07.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marked hypertriglyceridemia in a woman receiving metoprolol succinate","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2014.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}